Abstract
Two hundred and thirty five patients with central retinal vein occlusion (mean age 64.9 years, 95% CI (63.3, 66.5) years), comprising 221 white Europeans, 10 Asians and 4 West Indians) were studied over a 7 year period of whom 13.2% (n = 31) developed rubeosis (mean age 70.1 years, 95% CI (66.3, 73.9) years; all white Europeans). Comparisons were made with 31 of the original 235 CRVO patients who did not develop rubeosis, and who were individually matched for age, sex and ethnic origin. The 31 patients developing rubeosis were significantly older (p = 0.013) than the 204 patients not developing rubeosis (mean age 64.1 years, 95% CI (62.3, 65.9) years). There was no significant difference between the CRVO group with rubeosis and the uncomplicated matched CRVO group in the prevalence rates of hypertension (64.5% vs. 45.2%), hyperlipidaemia (48.4% vs. 38.7%) or diabetes mellitus (9.7% vs. 12.9%). We conclude that neovascular glaucoma is more likely to occur in older subjects with CRVO.
Similar content being viewed by others
Article PDF
References
Hayreh SS, Rajas P, Momntague P, Woolson RF . Ocular neovascularisation with retinal vascular occlusion. III. Incidence of ocular neovascularisation with retinal vein occlusion. Ophthalmology 1983;90:488–506.
Laatikainen L, Kohner EM, Khoury D, Blach RK . Panret-inal photocoagulation in central retinal vein occlusion: a randomised controlled clinical study. Br J Ophthalmol 1977;61:741–53.
Sinclair SH, Gradoudas ES . Prognosis for rubeosis iridis following central retinal vein occlusion. Br J Ophthalmol 1979;63:735–43.
Servais GE, Thompson HS, Hayreh SS . Relative afferent pupillary defect in central retinal vein occlusion. Ophthalmology 1986;93:301–3.
Laatikainen L, Khoner EM . Fluorescein angiography and its prognostic significance in central retinal vein occlusion. Br J Ophthalmol 1976;60:411–8.
Margalal LE, Donoso LA, Sanborn GE . Retinal ischaemia and risk of neovascularisation following central retinal vein obstruction. Ophthalmology 1982;89:1241–5.
Sabates R, Hirose T, McMeel JW . Electroretinography in the prognosis and classification of central retinal vein occlusion. Arch Ophthalmol 1983;101:232–5.
Kaye SB, Harding SP . Early electroretinography in unilateral central retinal vein occlusion as a predictor of rubeosis iridis. Arch Ophthalmol 1988; 106:353–6.
Johnson MA, Marcus S, Elman MJ, McPhee TJ . Neovascularisation in central retinal vein occlusion: electroretinographic findings. Arch Ophthalmol 1988; 106:348–52.
Dodson PM, Galton DJ, Hamilton AM, Blach RK . Retinal vein occlusion and the prevalence of lipoprotein abnormalities. Br J Ophthalmol 1982;66:161–4.
Dodson PM, Kritzinger EE . Management of retinal vein occlusion. BMJ 1987;295:1434–5.
Appiah AP, Trempé CL . Differences in contributory factors among hemicentral, central, and branch retinal vein occlusions. Ophthalmology 1989;96:364–6.
McGrath MA, Wechsler F, Hunyor AB, Penny R . Systemic factors contributory to retinal vein occlusion. Arch Intern Med 1978; 138:216–20.
Rothstein T . Bilateral central retinal vein closure as the initial manifestation of polycythemia. Am J Ophthalmol 1972;74:256–60.
Magargal LE, Brown GC, Augsburger JJ, Parrish RK II. Neovascular glaucoma following central retinal vein obstruction. Ophthalmology 1981;88:1095–101.
Cappin JM, Whitelocke R . The iris in central retinal vein thrombosis. Proc Soc Med 1974;67:1048–51.
Dodson PM, Kritzinger EE . Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion. Trans Ophthalmol Soc UK 1984; 104:114–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Keenan, J., Dodson, P. & Kritzinger, E. Are there medical conditions specifically underlying the development of rubeosis in central retinal vein occlusion?. Eye 7, 407–410 (1993). https://doi.org/10.1038/eye.1993.80
Issue Date:
DOI: https://doi.org/10.1038/eye.1993.80